サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1701961

血漿分画市場：製品別、部門別、用途別、エンドユーザー別、地域別、2025-2033年

Plasma Fractionation Market Report by Product, Sector, Application, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 137 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
血漿分画市場：製品別、部門別、用途別、エンドユーザー別、地域別、2025-2033年
出版日: 2025年04月01日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血漿分画市場の世界市場規模は2024年に264億米ドルに達しました。今後、同市場は2033年までに414億米ドルに達すると予測され、2025～2033年の成長率（CAGR）は4.86%です。慢性疾患の有病率の上昇、技術の進歩、ヘルスケアへの投資の増加は、市場成長を促進する主な要因の一部です。

血漿分画とは、提供された血漿を救命治療や医薬品に下流処理することを指します。遠心分離、深層ろ過、沈殿、クロマトグラフィーなどの機械的分離法を用いて、血漿を個々のタンパク質や血漿分画に分解します。現在では、アルコール濃度、時間、温度、pHを利用して、特定の治療用タンパク質を抽出する最新の分画法がいくつかあります。さらに、長年にわたる技術の複雑化と工程内でのウイルス減少治療の導入により、新しいタンパク質治療薬の開発と製品の純度と品質の向上がもたらされています。

血漿分画市場動向：

ヒト血漿から分画されるタンパク質製品は、感染症、先天性欠損症、希少血液疾患、免疫疾患、自己免疫疾患など、生命を脅かす疾患の予防、管理、治療に広く使用される重要な治療薬です。世界的に人口のかなりの部分でこれらの疾患の有病率が大幅に上昇していることが、市場成長を促す重要な要因の一つとなっています。さらに、生物学的製剤の品質保証に関する各国の管理機関による厳格な規制や標準管理・設定の実施により、メーカーはさらなる安全性を備えた血漿分画を開発しています。これとは別に、市場各社は研究開発（R&D）活動に資金を提供し、製品の有効性を向上させ、免疫グロブリンG（IgG）の回収率を高めて新たな血漿タンパク質を分離するための血漿製造技術の進歩を打ち出しています。さらに、地域の血漿資源を安全に利用できるよう、手頃な価格のウイルス不活化・処理技術の開発にも注力しています。このことは、収率の向上、プロセス経済性の維持、規制要件の増加に対処する必要性の高まりと相まって、今後数年間は良好な市場展望をもたらすと予想されます。

本レポートで扱う主な質問

  • 2024年の血漿分画市場の世界市場規模は？
  • 2025年～2033年の世界の血漿分画市場の予想成長率は？
  • 世界の血漿分画市場に対するCOVID-19の影響は？
  • 世界の血漿分画市場を牽引する主要因は何か？
  • 世界の血漿分画市場の製品別内訳は？
  • 世界の血漿分画市場の部門別内訳は？
  • 世界の血漿分画市場の用途別内訳は？
  • 世界の血漿分画市場のエンドユーザー別内訳は？
  • 世界の血漿分画市場における主要地域は？
  • 世界の血漿分画市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の血漿分画市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 免疫グロブリン
  • アルブミン
  • 凝固因子VIII
  • 凝固因子IX

第7章 市場内訳：部門別

  • 民間部門
  • 公共部門

第8章 市場内訳：用途別

  • 神経学
  • 免疫学
  • 血液学
  • その他

第9章 市場内訳：エンドユーザー別

  • 病院と診療所
  • 臨床研究ラボ
  • 学術機関

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • ADMA Biologics
    • Bio Products Laboratory Ltd.
    • Boccard
    • Grifols, S.A.
    • Hemarus Therapeutics Limited
    • Intas Pharmaceuticals Limited
    • LFB S.A.
    • Merck Group
    • Octapharma AG
    • PlasmaGen BioSciences Pvt. Ltd.
    • SK Plasma Co. Ltd.
    • Virchow Biotech Private Limited
図表

List of Figures

  • Figure 1: Global: Plasma Fractionation Market: Major Drivers and Challenges
  • Figure 2: Global: Plasma Fractionation Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Plasma Fractionation Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Plasma Fractionation Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Plasma Fractionation Market: Breakup by Sector (in %), 2024
  • Figure 6: Global: Plasma Fractionation Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Plasma Fractionation Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Plasma Fractionation Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Plasma Fractionation (Immunoglobulins) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Plasma Fractionation (Immunoglobulins) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Plasma Fractionation (Albumin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Plasma Fractionation (Albumin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Plasma Fractionation (Coagulation factor VIII) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Plasma Fractionation (Coagulation factor VIII) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Plasma Fractionation (Coagulation factor IX) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Plasma Fractionation (Coagulation factor IX) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Plasma Fractionation (Private Sector) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Plasma Fractionation (Private Sector) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Plasma Fractionation (Public Sector) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Plasma Fractionation (Public Sector) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Plasma Fractionation (Neurology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Plasma Fractionation (Neurology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Plasma Fractionation (Immunology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Plasma Fractionation (Immunology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Plasma Fractionation (Hematology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Plasma Fractionation (Hematology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Plasma Fractionation (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Plasma Fractionation (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Plasma Fractionation (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Plasma Fractionation (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Plasma Fractionation (Clinical Research Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Plasma Fractionation (Clinical Research Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Plasma Fractionation (Academic Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Plasma Fractionation (Academic Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: North America: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: North America: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: United States: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: United States: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Canada: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Canada: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Asia-Pacific: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Asia-Pacific: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: China: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: China: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Japan: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Japan: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: India: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: India: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: South Korea: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: South Korea: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Australia: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Australia: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Indonesia: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Indonesia: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Others: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Others: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Europe: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Europe: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Germany: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Germany: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: France: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: France: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: United Kingdom: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: United Kingdom: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Italy: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Italy: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Spain: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Spain: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Russia: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Russia: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Others: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Others: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Latin America: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Latin America: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Brazil: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Brazil: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Mexico: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Mexico: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Others: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Others: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Middle East and Africa: Plasma Fractionation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Middle East and Africa: Plasma Fractionation Market: Breakup by Country (in %), 2024
  • Figure 83: Middle East and Africa: Plasma Fractionation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Global: Plasma Fractionation Industry: SWOT Analysis
  • Figure 85: Global: Plasma Fractionation Industry: Value Chain Analysis
  • Figure 86: Global: Plasma Fractionation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Plasma Fractionation Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Plasma Fractionation Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Plasma Fractionation Market Forecast: Breakup by Sector (in Million USD), 2025-2033
  • Table 4: Global: Plasma Fractionation Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Plasma Fractionation Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Plasma Fractionation Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Plasma Fractionation Market: Competitive Structure
  • Table 8: Global: Plasma Fractionation Market: Key Players
目次
Product Code: SR112025A5973

The global plasma fractionation market size reached USD 26.4 Billion in 2024. Looking forward, the market is expected to reach USD 41.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.86% during 2025-2033. The rising prevalence of chronic diseases, technological advancements, and the increasing investment in healthcare are some of the major factors driving the market growth.

Plasma fractionation refers to the downstream processing of donated plasma into life-saving therapies and medicinal products. It breaks plasma into individual proteins or plasma fractions using mechanical separation methods, such as centrifugation, depth filtration, precipitation, and chromatography. Nowadays, several modern fractionation processes use alcohol concentrations, time, temperature, and pH to extract specific therapeutic proteins. Moreover, increasing technology complexity over the years and the introduction of in-process viral reduction treatments have resulted in the development of new protein therapeutics and improvement in product purity and quality.

Plasma Fractionation Market Trends:

Protein products fractionated from human plasma are an essential class of therapeutics widely used to prevent, manage, and treat life-threatening conditions, such as infections, congenital deficiencies, rare blood disorders, immunologic disorders, and autoimmune disorders. A significant rise in the prevalence of these conditions among a significant part of the population globally represents one of the key factors impelling the market growth. In addition, manufacturers are developing plasma fractionation with additional safety features due to the implementation of stringent regulations and standard controls and settings by governing agencies of numerous countries on quality assurance of biological products. Apart from this, market players are financing research and development (R&D) activities to launch advancement in plasma production technology to improve product efficacy and enhance recovery of immunoglobulin G (IgG) to isolate new plasma proteins. Furthermore, they are focusing on developing affordable viral inactivation and processing technologies that allow utilization of local plasma resources safely. This, in confluence with the escalating need to improve yield, maintain process economics, and manage increasing regulatory requirements, is anticipated to provide a favorable market outlook in the coming years.

Key Market Segmentation:

Breakup by Product:

  • Immunoglobulins
  • Albumin
  • Coagulation factor VIII
  • Coagulation factor IX

Breakup by Sector:

  • Private Sector
  • Public Sector

Breakup by Application:

  • Neurology
  • Immunology
  • Hematology
  • Other Applications

Breakup by End User:

  • Hospitals and Clinics
  • Clinical Research Laboratories
  • Academic Institutes

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being ADMA Biologics, Bio Products Laboratory Ltd., Boccard, Grifols, S.A., Hemarus Therapeutics Limited, Intas Pharmaceuticals Limited, LFB S.A., Merck Group, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., SK Plasma Co. Ltd. and Virchow Biotech Private Limited.

Key Questions Answered in This Report

  • 1.What was the size of the global plasma fractionation market in 2024?
  • 2.What is the expected growth rate of the global plasma fractionation market during 2025-2033?
  • 3.What has been the impact of COVID-19 on the global plasma fractionation market?
  • 4.What are the key factors driving the global plasma fractionation market?
  • 5.What is the breakup of the global plasma fractionation market based on the product?
  • 6.What is the breakup of the global plasma fractionation market based on the sector?
  • 7.What is the breakup of the global plasma fractionation market based on the application?
  • 8.What is the breakup of the global plasma fractionation market based on the end user?
  • 9.What are the key regions in the global plasma fractionation market?
  • 10.Who are the key players/companies in the global plasma fractionation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Plasma Fractionation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Immunoglobulins
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Albumin
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Coagulation factor VIII
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Coagulation factor IX
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Sector

  • 7.1 Private Sector
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Public Sector
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Neurology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Immunology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hematology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Other Applications
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinical Research Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Academic Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 ADMA Biologics
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 Bio Products Laboratory Ltd.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Boccard
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Grifols, S.A.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Hemarus Therapeutics Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Intas Pharmaceuticals Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 LFB S.A.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Merck Group
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Octapharma AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 SWOT Analysis
    • 15.3.10 PlasmaGen BioSciences Pvt. Ltd.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 SK Plasma Co. Ltd.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Virchow Biotech Private Limited
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio